Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
OpenUpdated: Oct 30, 2025
Summary
The grant aims to fund preclinical and patient-based studies that explore how incretin mimetics affect cancer risk, encouraging researchers to investigate the long-term implications of these agents rather than just short-term outcomes. Eligible applicants include various nonprofit organizations, government entities, small and for-profit businesses, educational institutions, and other specified groups such as Native American tribal organizations and historically black colleges. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for further information.
Full Description
Description
Eligibility
Eligible applicants
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Government
- County governments
- State governments
- Public and Indian housing authorities
- City or township governments
- Special district governments
- Federally recognized Native American tribal governments
Business
- Small businesses
- For-profit organizations other than small businesses
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.